Cures for Cancer? A new study shows incredible results from cheap generic drug Fenbendazole

You won’t hear much about Fenbendazole from the regular pipeline of medical information. There could be many reasons for that. For one, it’s primarily known for it’s use in veterinary medicine. Somehow during COVID the medical information pipeline convinced millions that if a drug is used on horses or other animals it couldn’t work for humans. Not sure how they got away with that one considering the use of animal trials for much of modern medical history.

Another possible reason, one that makes at least as much sense, is that there’s no business case for Fenbendazole. It’s been around for decades and its patent expired in the early 1990’s. That means it’s considered a generic drug that a pharmaceutical company from India could (and does) produce in mass quantities for very little profit (compared to non-generics).

So Fenbendazole is an inexpensive, widely accessible antiparasitic drug used in veterinary medicine. During the COVID pandemic a number of doctors, desperate for a suitable treatment, tried it with reportedly great levels of success. Over some time they discovered it might be useful elsewhere. Some doctors are using Fenbendazole to help treat late stage cancer. Often this is prescribed when the regular treatments clearly aren’t working and cancer is approaching or has already been declared stage 4.

What they’ve found at least in some cases is astounding results. This has resulted in a new study which medical researcher Dr. John Campbell shares in this video.

Don't Miss

Will Paramount turn the tide of legacy media and entertainment?

Duane Rolheiser

After 15 years as a TV reporter with Global and CBC and as news director of RDTV in Red Deer, Duane set out on his own 2008 as a visual storyteller. During this period, he became fascinated with a burgeoning online world and how it could better serve local communities. This fascination led to Todayville, launched in 2016.

Follow Author

Cures for Cancer? A new study shows incredible results from cheap generic drug Fenbendazole

Environment / 1 week ago

The era of Climate Change Alarmism is over

Also Interesting / 2 weeks ago

How Classic Slots Features Are Evolving

Dr John Campbell

Cancer cure experiences

Published on December 1, 2024

Duane Rolheiser

From the YouTube page of Dr John Campbell

UK health instructor and researcher Dr. John Campbell has been hearing anecdotally from cancer survivors who say they’ve been cured by the use of inexpensive drugs ivermectin and fenbendazole. In fact he’s been hearing from so many survivors that he’s calling on cancer researchers to undertake peer reviewed studies as soon as possible.

Viewers share their experiences of their approaches to cancer treatment.

COVID-19

Japanese study shows disturbing increase in cancer related deaths during the Covid pandemic

Published on April 19, 2024

Duane Rolheiser

From Cureus.com

The study is called:

Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan

During the COVID-19 pandemic, excess deaths including cancer have become a concern in Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age-adjusted mortality rates (AMRs) for different types of cancer in Japan changed during the COVID-19 pandemic (2020-2022).

Introduction

The COVID-19 pandemic began in December 2019 in Wuhan, China, and was first detected in Japan in January 2020. In response, a range of healthcare and socio-economic restrictions were implemented to curb the spread of the disease. Since February 2021, the mRNA-lipid nanoparticle (mRNA-LNP) vaccine has been available for emergency use and is recommended for all individuals aged six months and older, especially those at high risk.

As of March 2023, 80% of the Japanese population had received their first and second doses, 68% had received their third dose, and 45% had received their fourth dose [1]. Despite these national measures, 33.8 million people had been infected, and 74,500 deaths had been attributed to COVID-19 in Japan by the end of April 2023.

Additionally, excess deaths from causes other than COVID-19 have been reported in various countries [2-6], including deaths from cancer [7-10], and Japan is no exception [11,12]. Cancer is the leading cause of death in Japan, accounting for one-fourth of all deaths. Therefore, it is essential to understand the effects of the pandemic on mortality rates of cancer from 2020 to 2022. Age adjustment is necessary for accurate evaluation, especially in diseases such as cancer that tend to occur in elderly adults.

Japan has several characteristics that make it ideal for analyzing the impact of the pandemic on cancer mortality rates, including its large population of 123 million, availability of official statistics, and the high 80% accuracy rate of death certificates according to autopsy studies [13].

Conclusions

Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination rather than COVID-19 infection itself or reduced cancer care due to the lockdown. The significance of this possibility warrants further studies.